BILE ACIDS ARE SYNTHESIZED from cholesterol in the liver and secreted across the canalicular membrane. Along with other biliary constituents, bile acids enter the small intestine, where they facilitate the absorption of dietary lipids and fat-soluble vitamins. Bile acids are efficiently absorbed from the small intestine through a combination of passive absorption in the proximal small intestine and active absorption in the distal ileum. The absorbed bile acids are then returned to the liver in the portal circulation and resecreted into bile (20) . The active absorption of bile acids in the terminal ileum is mediated by the well-characterized ileal apical Na ϩ -bile acid transporter (ASBT) (31) . This Na ϩ -and potential-driven (47) transporter moves bile acids from the lumen of the small intestine across the apical brush-border membrane. The bile acids are then shuttled to the basolateral membrane and secreted by an anion exchange mechanism (46) . Several observations suggest that the terminal ileum is the major site of bile acid reabsorption in humans and experimental animal models. These include the finding that there is little decrease in intraluminal bile acid concentration before the ileum (18) and the appearance of bile acid malabsorption after ileal resection (21) . More recent studies using in situ perfused intestinal segments to measure bile acid absorption (32) have also demonstrated that ileal bile acid transport is a high-capacity system sufficient to account for the biliary output of bile acids. The consensus from these studies was that the ileal active transport system is the major route for conjugated bile acid uptake, whereas the passive or facilitative absorption down the length of the small intestine may be significant for unconjugated and some glycineconjugated bile acids.
In contrast to the ileal absorption of bile acids, little is known regarding the mechanism for jejunal transport of bile acids. A fraction of the glycine conjugates and unconjugated bile acids are protonated and may be absorbed by passive diffusion across the apical brushborder membrane. However, there is emerging evidence for carrier-mediated transport of bile acids in the proximal small intestine in addition to membrane diffusion. In vivo uptake and cis-inhibition studies demonstrated bile acid specificity consistent with a facilitative carrier (3, 5) . More recently, Amelsburg and co-workers (4) demonstrated an anion exchange mechanism for conjugated bile acid uptake in rat jejunal brush-border membranes. The properties of this transport system are similar to those ascribed to the family of organic anion-transporting polypeptides (oatp).
The rat oatp family includes the bile acid and organic solute transporters oatp1 (22) , oatp2 (35) , oatp3 (1) , and lst-1/oatp4 (8, 23) , the renal methotrexate transporters OAT-K1 (38) , and the PG transporter PGT (25) .
Two human members of the family are LST-1 (2), the human ortholog of lst-1, and OATP-A (28), for which a rodent ortholog has not been identified. The mouse ortholog of rat oatp1 was recently identified (16) . Although several members of this family transport bile acids, Northern blot and RT-PCR analysis indicate that they are not expressed in the small intestine (2, 22, 33, 38) . To identify other bile acid transporters that may be involved in the apical uptake or basolateral secretion of bile acids, we employed low-stringency PCR and rapid amplification of cDNA ends (RACE) strategies to isolate a rat oatp3 cDNA from rat small intestine. The mRNA and protein expression properties, substrate specificity, and membrane localization determined in this work suggest that rat oatp3 is an intestinal apical transporter that participates in bile acid absorption down the length of the small intestine. The mouse oatp3 cDNA was also obtained by identification of mouse EST clones and subsequent 5Ј-RACE. Its chromosomal location suggests that oatp3 is the ortholog of human OATP-A.
MATERIALS AND METHODS

Materials.
Male Sprague-Dawley rats were purchased from Zivic Miller Laboratories (Zelienopole, PA). [ 3 H]taurocholic acid (2.0-2.6 Ci/mmol), [2, H]cholate (27.5 Ci/mmol), and [ 3 H(G)]digoxin (19 Ci/mmol) were purchased from NEN Life Sciences Products (Boston, MA). Other tritiated bile acids (2-60 Ci/mmol) were obtained from Dr. Alan Hofmann (University of California, San Diego) and were synthesized as described previously (12, 37 125 I-labeled microcystin was kindly provided by Dr. Maria Runnegar (University of Southern California). Unlabeled bile acids were purchased from Sigma Chemical (St. Louis, MO) and Calbiochem (San Diego, CA). DIDS was purchased from Sigma Chemical. COS-1 cells were maintained in medium A, which consists of DMEM containing 4,500 mg/l D-glucose, 10% (vol/vol) FCS, 100 U/ml penicillin, and 100 g/ml streptomycin (Life Technologies, Gaithersburg, MD). Madin-Darby canine kidney (MDCK) cells were obtained from the American Type Culture Collection and maintained in medium B, which consists of DMEM containing 1,000 mg/l D-glucose, 10% (vol/vol) FCS, 100 U/ml penicillin, and 100 g/ml streptomycin. SpragueDawley rat hepatocytes were isolated by collagenase perfusion (7) and kindly provided by Dr. Tom Thuren (Dept. of Internal Medicine, Wake Forest University). SpragueDawley rat retinas were kindly provided by Dr. Elena Grigorenko (Dept. of Neurosurgery, Wake Forest University). A mouse/hamster radiation hybrid panel (catalog no. RH04.02) was purchased from Research Genetics (Huntsville, AL). The oligonucleotide primers are listed in Table 1 .
Isolation of the rat oatp3 cDNA. cDNA was synthesized from rat ileal poly(A) RNA (Superscript Kit, Life Technologies) and used with primers RBOATP3 and RBOATP4 to PCR amplify a 297-bp product. Sequence analysis revealed that the PCR product was distinct but related to the previously reported oatp1 and oatp2 cDNA clones. A larger 1,083-bp oatp3 fragment was PCR amplified using RBOATP4 and a degenerate primer corresponding to amino acids 187-193 of oatp1 (oligonucleotide OATP5). The RACE procedure was employed to obtain the remainder of the coding region, the 3Ј-untranslated region, and a portion of the 5Ј-untranslated region of rat oatp3. For 3Ј-RACE, rat ileal poly(A) RNA was reverse transcribed using the oligo(dT) adapter primer AP2. The primer pairs RBOATP3/UAP2 and RIOATP1/UAP2 were employed in the primary and secondary PCR amplifications, respectively. The PCR-amplified product was isolated from a 0.8% (wt/vol) agarose gel, subcloned into pBluescript II KS, and sequenced using a Perkin-Elmer ABI Prism 377 sequencer. For 5Ј-RACE, a rat ileal double-stranded, adapter-ligated cDNA library was generated using 1 g of rat ileal poly(A) RNA (Marathon cDNA Amplification Kit, Clontech, Palo Alto, CA). The primer pairs AP1/RIOATP8 and NAP2/RIOATP10 were employed in the primary and secondary PCR amplifications, respectively, of the adapter-ligated cDNA. Both reactions were performed as suggested by the manufacturer. The product of this secondary amplification reaction was subcloned and yielded the oatp3 sequence corresponding to nt 244-861. A second 5Ј-RACE reaction was performed using primer pairs AP1/RIOATP16 and NAP2/ RIOATP18 in the primary and secondary PCR amplifications, respectively. The amplified product of this reaction was sequenced and corresponded to oatp3 nt 1-361.
Construction of rat oatp and ASBT expression plasmids. A rat oatp3 expression plasmid was constructed as follows. First-strand cDNA was synthesized from rat ileal poly(A) RNA using a cDNA synthesis kit (Superscript Kit, Life Technologies). A pair of oligonucleotide primers, RIOATPK and RIOATP12, corresponding to rat oatp3 nt 238-263 and 2259-2283, was used for PCR amplification with the rat ileal cDNA. Long PCR amplification conditions (6) were employed using 2.5 U of Taq polymerase (Life Technologies) and 0.25 U of Pfu polymerase (Stratagene, La Jolla, CA) at an annealing temperature of 65°C. After PCR amplification, the 2,049-bp product was isolated from a 0.8% (wt/vol) agarose gel. The fragment was treated with T4 DNA polymerase, phosphorylated with T4 polynucleotide kinase, and ligated into Sma I-digested pCMV5. For the rat oatp1 and oatp2 expression vectors, the coding regions were amplified from rat liver cDNA using the long PCR conditions and oatp1-specific oligonucleotide primers RLOATP1 and RLOATP2 and oatp2-specific oligonucleotide primers RBOATP1 and RBOATP2. The 2,151-bp oatp1 product was subcloned into EcoR Vdigested pcDNAI (Invitrogen), and the 2,139-bp oatp2 product was subcloned into EcoR V-digested pcDNA3. For the rat ASBT expression plasmid, an EcoR I-Xho I fragment from BS37C1 (41) encompassing the rat ASBT coding region, as well as 115 and 83 bp of 5Ј-and 3Ј-untranslated sequences, respectively, was subcloned into EcoR I-and Sal I-digested pCMV5. The cDNA inserts for all the transporter expression plasmids were sequenced on both strands using a PerkinElmer ABI Prism 377 sequencer.
Transport assays in transfected COS cells. COS-1 cells were maintained in monolayer at 37°C in an atmosphere of 5% CO 2 in medium A. On day 0, 100-mm plates were seeded with 1.5 ϫ 10 6 COS cells. On day 1, each plate of cells was transfected using 18 l of the FuGENE 6 Transfection Reagent (Boehringer Mannheim, Indianapolis, IN) and 6 g of the indicated plasmid. On day 2, the transfected cells were trypsinized, pooled, and replated at 2.2 ϫ 10 5 cells/dish in 35-mm plates or at 7 ϫ 10 4 cells/well in 24-well plates. On day 4, the cells were incubated at 37°C in a Hanks' balanced salt solution (HBSS) containing 137 mM Na ϩ or K ϩ in the presence of the indicated concentration of radiolabeled solute for the indicated times. For the DIDS inhibition experiment, the cells were preincubated in HBSS containing 137 mM NaCl and the indicated concentrations of DIDS for 30 min at 37°C. The cells were washed twice and then incubated for 30 min at 37°C in HBSS containing 10 M [ 3 H]taurocholate and the indicated concentrations of DIDS. The cells were then washed and harvested to determine cell-associated radioactivity and protein, as described previously (10) .
Transport assays in stably transfected MDCK cells. Stable expression of the human ileal apical Na ϩ -bile acid transporter and the rat oatp3 in MDCK cells was achieved as follows. On day 0, 100-mm plates were seeded with 5 ϫ 10 5 MDCK cells. On day 3, the cells were transfected with 5.5 g of the transporter expression plasmid plus 0.5 g of pSV 3 Neo using the FuGENE 6 Transfection Reagent. On day 5, the cells were switched to medium B containing 700 g/ml G-418. After selection for 15 days, individual colonies were picked, expanded in 24-well plates, and screened for [ 3 H]taurocholate uptake. The colonies expressing the highest taurocholate uptake activity were selected; the MDCK-oatp3 cells were further isolated through one round of dilution cloning. For the dilution cloning, each colony was expanded and then replated at ϳ10 cells/well in a 24-well plate. These cells were expanded, transferred to duplicate plates, and assayed for taurocholate uptake activity. The final MDCK cell clones were maintained in medium B containing 350 g/ml G-418.
For the DIDS inhibition, bile acid uptake kinetics, and non-bile acid substrate uptake experiments, the MDCK and MDCK-oatp3 cells were seeded on day 0 in 24-well plates at 7 ϫ 10 4 cells/well, induced with 10 mM sodium butyrate on day 2, and assayed for activity on day 3. The DIDS sensitivity of taurocholate transport was assayed as described for the transiently transfected COS cells, except the MDCK cells were incubated for 2.5 min at 37°C in HBSS containing 10 M [ 3 H]taurocholate. To determine the kinetics of bile acid transport, the cells were incubated with increasing concentrations of the radiolabeled bile acids in HBSS containing 137 mM choline for 5 min at 37°C. The cells were incubated in duplicate with six different concentrations of bile acid from 1 to 100 M. The Michaelis-Menten constants (K m ) and maximal velocities (V max ) were determined by Eadie-Hofstee analysis. A similar procedure was used to examine the uptake of the non-bile acid substrates (folic acid, methotrexate, digoxin, and microcystin).
For membrane localization transport assays, untransfected MDCK, stably transfected MDCK-oatp3, or stably transfected MDCK-ASBT cells were seeded onto 12-mm Transwell filter inserts (Costar, Cambridge, MA) at 8. 
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radiolabeled inulin across the cell monolayer from the apical and basolateral chambers was Ͻ1.5 and 0.3%, respectively. On day 6, the cells were assayed for [ 3 H]taurocholate uptake. The cell monolayers were washed with warm PBS, and each well was incubated with the indicated volumes of HBSS plus 10 M [ 3 H]taurocholate added to the apical (0.5 ml) or basolateral (1.0 ml) chamber. After 30 min at 37°C, the medium was removed, and the cells were washed in ice-cold PBS and harvested to determine cell-associated radioactivity and protein (10) .
oatp3 mRNA tissue expression. RT-PCR analysis was used to compare the liver and small intestinal expression of oatp1, oatp2, and oatp3 mRNA. Total cellular RNA was isolated using TRIzol Reagent (Life Technologies) as suggested by the manufacturer. Poly(A) RNA was prepared by oligo(dT)-cellulose chromatography using a MicroPoly(A) Pure Kit (Ambion, Austin, TX). The RNA was then reverse transcribed using a random-hexamer primer and a cDNA synthesis kit (Superscript Kit, Life Technologies). For the PCR amplification of oatp2 and oatp3 (50 l; 30 cycles at 94°C for 45 s, 65°C for 1 min, and 72°C for 2 min), the reactions contained 1 l of cDNA, 0.7 M primers, 0.2 mM dNTPs, 2 mM MgCl 2 , and 0.5 U of Taq polymerase. Oligonucleotide primers specific for oatp2 (RBOATP1 and RBOATP4) and oatp3 (RIOATP1 and RIOATP6) were used to PCR amplify the 1,726-and 972-bp products, respectively. The oligonucleotide primers RLOATP1 and RLOATP6 and an annealing temperature of 60°C were used to amplify a 531-bp fragment for oatp1. For each primer pair, a reaction containing no cDNA template was included as a control for reagent contamination. Rat liver cDNA, small intestine cDNA, and mock cDNA reactions, to which no reverse transcriptase was added, were also PCR amplified using primers CYCF and CYCR for cyclophilin as a control for cDNA load and genomic DNA contamination. The amplified products were separated on a 1% (wt/vol) agarose gel and visualized with ethidium bromide.
RNase protection assays (RPAs) were performed using an RPA II Kit (Ambion) and the indicated amount of RNA isolated from rat tissues. The antisense 32 P-labeled riboprobes were transcribed using [␣-
32 P]UTP (800 Ci/mmol) and T7 RNA polymerase (Maxiscript Kit, Ambion) from pBluescript II KS-rat ASBT (nt 1-237) (41) that was linearized with EcoR I or from pBluescript II KS-rat oatp3 (nt 1993-2404) that was linearized with Pst I or Nsi I. The sizes of the undigested probes/protected riboprobe fragments were 410/ 349 nt for oatp3 (Pst I-digested plasmid; oatp3 nt 2051-2404), 165/116 nt for oatp3 (Nsi I-digested plasmid; oatp3 nt 2288-2404), and 336/237 nt for ASBT (nt 1-237). A 295-nt oatp1 probe was also synthesized from pBluescript II KS-rat oatp1 (nt 1-210) (22) that protected 86 nt of 5Ј-untranslated sequence and 124 nt of coding sequence, and a 487-nt oatp3 probe was synthesized that protected 237 nt of 5Ј-untranslated region and 149 nt of coding sequence. Unlabeled sensestrand transcripts were synthesized from the pBluescript II KS-rat oatp3 and rat ASBT constructs using T3 RNA polymerase (Maxiscript Kit, Ambion) and used as standards for quantitation. The radiolabeled riboprobes were isolated by preparative electrophoresis on a 5% acrylamide-8 M urea denaturing gel and elution into 0.5 M ammonium acetate, 1 mM EDTA, and 0.2% SDS at 37°C. The individual antisense probes were hybridized with tissue RNA at 42°C for Ͼ12 h. Single-stranded riboprobe was digested with a mixture of RNase A and T1, and the protected products were resolved by electrophoresis on a 6% acrylamide-7 M urea denaturing gel. The dried gels were exposed to Amersham Hyperfilm with an intensifying screen at Ϫ70°C. The amount of protected product was quantified using a PhosphorImager (Molecular Dynamics).
Antibody preparation. The cDNA coding for the carboxyterminal 47 amino acids of rat oatp3 was PCR amplified, subcloned into pGEX 3X (Pharmacia), and sequenced. The glutathione S-transferase (GST)-oatp3 fusion protein was purified from Escherichia coli cytosol by glutathione affinity chromatography, as described elsewhere (42) . Three New Zealand White rabbits were immunized with 500 g of the GST-oatp3 fusion protein in Freund's complete adjuvant, and an Ig-enriched fraction was prepared from immune serum by precipitation with 50% ammonium sulfate. Affinity purification of the anti-oatp3 antibody was performed by sequential affinity chromatography using GST-coupled agarose to remove GST-specific antibodies followed by GST-oatp3-coupled agarose according to the manufacturer's instructions (AminoLink Immobilization Kit, Pierce, Rockford, IL). The affinitypurified antibody was stored at Ϫ70°C and subjected to only one freeze-thaw cycle.
Immunolocalization. Sections (6 m) of rat intestine or 35-mm dishes of COS cells were fixed in 3.7% formaldehyde, washed in PBS, and incubated in blocking solution (PBS containing 1% BSA and 0.1% saponin) for 10 min at room temperature. The sections were then incubated with 2.9 g/ml affinity-purified anti-oatp3-GST fusion protein antibody or preimmune Ig (50% ammonium sulfate-precipitated fraction) in the blocking solution for 0.5-1.5 h at room temperature. The sections were washed four times in PBS and once in the blocking solution. The sections were then incubated with 25 g/ml rhodamine-conjugated goat anti-rabbit IgG secondary antibody (Jackson ImmunoResearch Laboratories) in blocking solution for 0.5-1.5 h at room temperature. After four washes with PBS, the sections were fixed in 3.7% formaldehyde for 10 min and viewed using a Zeiss Axioplane 2 fluorescence microscope equipped with rhodamine epifluorescence optics. Images were captured using a Dage 300 charge-coupled device digital camera. For each experiment, a section or dish was incubated with the secondary antibody alone to determine background fluorescence.
Identification of the mouse oatp3 cDNA. Oligonucleotide primers Moatp3-6 and Moatp3-4 were designed on the basis of the 3Ј-untranslated sequence of two mouse EST clones (GenBank accession nos. AA690580 and AA612385) and used to obtain the 5Ј-untranslated sequence and complete coding region sequence of the mouse oatp3 cDNA by 5Ј-RACE (Smart Race Kit, Clontech). Briefly, first-strand cDNA was synthesized from 1 g of mouse brain poly(A) RNA (Clontech) using an oligo(dT) primer. During the first-strand synthesis, a 5Ј-adapter sequence was added to the cDNA. The primer pairs UPM/Moatp3-6 and NUP/Moatp3-4 were employed in the primary and secondary PCR amplifications, respectively, of the cDNA. The PCR-amplified product was isolated from a 0.8% (wt/vol) agarose gel, subcloned into pBluescript II KS, and sequenced using a Perkin-Elmer ABI Prism 377 sequencer.
Chromosomal localization of the mouse oatp3 gene. The oatp3-specific oligonucleotide primers Moatp3-3 and Moatp3-5 were designed on the basis of the untranslated sequence of the mouse oatp3 and used to screen a whole mouse genome/hamster radiation hybrid panel (Research Genetics) by PCR amplification. The reactions contained 18.65 ng of the panel DNA, 50 mM KCl, 10 mM Tris ⅐ HCl, pH 8.2, 1.5 mM MgCl 2 , 0.2 mM dNTPs, each oligo at 0.4 M, and 0.5 U of Taq polymerase. Reactions containing mouse or hamster genomic DNA or no template were also included as controls. The reactions underwent 35 cycles in a GeneAmp PCR System 9700 (PE Applied Biosystems, Foster City, CA) at 94°C for 40 s, 59°C for 40 s, and 72°C for 40 s. The PCR products were analyzed on 1% TAE agarose gels. The hybrid panel DNA samples were scored as positive or negative for the 216-bp mouse oatp3 product, and the retention pattern was submitted to the Jackson Laboratories Mouse Radiation Hybrid Database (http://www.jax.org/resources/documents/ cmdata/rhmap/rhsubmit.html) for analysis.
RESULTS
Isolation of oatp3 cDNA from rat intestine. To isolate additional components of the intestinal bile acid transport system, a 297-bp fragment of a novel oatp was identified from rat ileal cDNA using oatp2-specific oligonucleotide primers and low-stringency PCR. A combination of RACE and PCR amplification was then used to obtain the complete 2,765-bp cDNA, designated oatp3 (GenBank accession no. AF083469). This complete intestinal oatp cDNA includes a 237-bp 5Ј-untranslated region, a 2,010-bp open reading frame, and a 518-bp 3Ј-untranslated region. The 3Ј-untranslated sequence contains a canonical polyadenylation signal (AATAAA) located at position 2747 and is followed by a 17-nt poly(A) tail. The initiator methionine lies in an appropriate consensus for initiation of translation (26) and is preceded by an in-frame stop codon. The three upstream ATG codons located in the predicted 5Ј-untranslated region are closely followed by in-frame stop codons. The 2,010-bp open reading frame encodes a 670-amino acid polypeptide with a calculated molecular mass of 74,496 Da. The intestinal oatp cDNA sequence was nearly identical to the oatp3 that was identified from rat retina (1) (GenBank accession no. AF041105), except for five nucleotide changes at positions 334, 401, 445, 1864, and 1865. These nucleotide substitutions result in four amino acid differences between the retinal and ileal oatp3 clones (retinal clone residue listed first: Q33K, I55T, F70L, and K543E). These differences may be due to PCR errors, sequencing errors, or polymorphisms; in each case, the nucleotide sequence reported here changed the predicted amino acid to a residue that matched the oatp1/2 consensus. A search of available nucleic acid databases revealed that the rat oatp3 protein sequence is 81, 82, 77, 40, and 36% identical to that of rat oatp1 (22) (GenBank accession no. L19031), oatp2 (35) (GenBank accession no. U88036), OAT-K1 (38), (GenBank accession no. D79981), lst-1 (23) (GenBank accession no. AF147740), and PGT (25) (GenBank accession no. M64862), respectively. Hidden Markov model analysis (http://www.enzim.hu/hmmtop) of the protein sequence predicted a topology with 12 transmembrane domains, similar to other members of the oatp family (45) .
Transport properties of oatp3. To examine the kinetics of oatp3-mediated bile acid uptake, transfected COS cells were incubated with increasing concentrations of [ 3 H]taurocholate for 2.5 min at 37°C. Previous studies had shown that transport of [ 3 H]taurocholate by oatp3 was linear up to 5 min (Fig. 1, inset) . The transport of [ 3 H]taurocholate by oatp3-transfected COS cells was saturable (Fig. 1) , with an apparent K m of 30 M and a V max of 240 pmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 . To compare the bile acid substrate specificity of the rat oatp3 and ASBT, transfected COS cells were incubated for 2.5 min with 10 M radiolabeled bile acid, and uptake was quantitated. Rat oatp3 and ASBT transport all the major species of bile acids, but ASBT transported them at a greater rate (Fig. 2) . Oatp3 transported glycineconjugated bile acids more rapidly than taurine conjugates. This preference is particularly evident for the glycine conjugates of deoxycholate and ursodeoxycholate, which exhibited initial uptake rates that were 3.6-and 2.6-fold, respectively, greater than the corresponding taurine conjugates. Also, oatp3 transported the dihydroxy bile acids more rapidly than the trihydroxy bile acids for glycine and taurine conjugates (3.5-, 2-, and 3.9-fold over glycocholate for glycodeoxycholate, glycochenodeoxycholate, and glycoursodeoxycholate, respectively; 1.4-, 2.3-, and 2.2-fold over taurocholate for taurodeoxycholate, taurochenodeoxycholate, and tauroursodeoxycholate, respectively). In contrast, ASBT showed neither of these trends for bile acid transport rate.
The kinetics of oatp3-mediated uptake of the different bile acids were determined using stably transfected MDCK cells ( Table 2 ). The K m values for the conjugated bile acids were more influenced by the number of hydroxyl groups on the steroid nucleus than by the type of conjugation. The dihydroxy bile acids had K m values ranging from 4.3 to 7.0 M, and taurocholate and glycocholate had K m values of 20.9 and 15.4 M, respectively. The oatp3-mediated uptake of four non- bile acid substrates transported by other members of the oatp family (14, 35, 38) was also examined using the MDCK-oatp3 stable cells. In these studies, oatp3 exhibited narrower substrate specificity and did not show appreciable transport of the nutrient folate, the cyanobacterial toxin microcystin, or the drugs methotrexate and digoxin (data not shown).
Transport mediated by previously identified members of the oatp family is Na ϩ independent (22, 29, 35, 38) and sensitive to the general anion transport inhibitor DIDS (29, 33, 38) . To determine whether oatp3 shares these properties, oatp3-transfected COS cells were incubated in a modified HBSS containing 137 mM Na ϩ or an equal concentration of K ϩ . Oatp3-mediated [ 3 H]taurocholate uptake was similar in the presence or absence of Na ϩ (Fig. 3, inset) . Uptake of [ 3 H]taurocholate by oatp3 stably transfected MDCK cells (Fig. 3) or by oatp3 transiently transfected COS cells (data not shown) was inhibited by preincubation with DIDS; half-maximal inhibition was observed at ϳ115 M.
Analysis of oatp3 membrane expression. The membrane localization of oatp3 was examined in the stably transfected MDCK cells. Figure 4 shows the cellular accumulation of [ 3 H]taurocholate from the apical and basolateral chambers in monolayers of the parental MDCK cells and MDCK cells stably transfected with the human ASBT (MDCK-ASBT) and the rat oatp3 (MDCK-oatp3). The parental MDCK and MDCK-ASBT cells were examined as a negative and positive control, respectively. Taurocholate uptake was expressed only on the apical surface for the human ASBT-transfected MDCK cells (Fig. 4A ), in agreement with previous studies of the rat ASBT (43) . These findings indicate that the transfected MDCK cells reproduced the normal trafficking for this bile acid transporter. Cellular taurocholate accumulation from the apical chamber was 26-fold greater for the MDCK-oatp3 cells than for K m , Michaelis constant; V max , maximal velocity. Madin-Darby canine kidney (MDCK) cells were stably transfected with the rat oatp3 and assayed for uptake of radiolabeled bile acid as described in the legend to Fig. 1. the parental MDCK cells (Fig. 4B) . In contrast, taurocholate uptake from the basolateral chamber was similar in the parental MDCK and oatp3 stably transfected MDCK cells.
Analysis of rat oatp3 tissue expression. RT-PCR and RPA were used to investigate the expression of oatp3 in liver and intestine. As shown in Fig. 5A , oatp1 and oatp2 mRNAs were detected in rat liver, but not rat small intestine, cDNA. In contrast, oatp3 was readily detected in small intestine, with only a faint but reproducible signal amplified from rat liver cDNA. RPA analysis of the horizontal gradient of oatp3 mRNA expression down the length of the small intestine is shown in Fig. 5B . The assay employed a 32 P-labeled oatp3 probe containing 199 nt of coding sequence and 150 nt of 3Ј-untranslated region. Oatp3 mRNA was present at ϳ0.04 pg/g total RNA and was expressed at similar levels down the length of the small intestine. This oatp3 probe could potentially cross-hybridize with other members of the family. However, no smaller cross-hybridizing products were detected with the oatp3 probe, nor was a protected fragment detected with an oatp1-specific probe in the RPA analysis of the intestinal RNAs (data not shown). The absence of cross-hybridizing related oatp transcripts in small intestine agrees with the RT-PCR analysis (Fig. 5A ) and previous studies of OAT-K1 mRNA expression (38) .
In contrast to oatp3 mRNA, rat ASBT mRNA was expressed only in the terminal ileum, as reported previously (9) . In addition to the protected ASBT fragment of the expected size (237 nt, including 106 nt of 5Ј-untranslated region and 131 nt of coding sequence), a smaller 210-nt fragment was also detected that may result from alternative transcription start sites (Dr. Ben Shneider, personal communication). The amount of ASBT mRNA expressed in rat terminal ileum (segment 9) was ϳ162 pg/g total RNA.
RPA analysis of oatp3 mRNA expression in other rat tissues is shown in Fig. 6 . For this analysis, a 32 Plabeled probe encompassing 116 nt of only divergent 3Ј-untranslated region was used. This region was selected since preliminary results with coding regioncontaining probes indicated significant cross-hybridization with related oatp mRNA in some tissues. For example, no protected product was observed using the 3Ј-untranslated region probe for RPA analysis of kidney RNA (Fig. 6) . However, an RPA probe containing oatp3 coding and 5Ј-untranslated region sequence protected a product that was significantly smaller than the oatp3 predicted size. The size of the protected fragment matched a segment of the coding region portion of the probe that shared extensive sequence identity (Ͼ90%) with related oatp cDNA clones (data not shown). The oatp3 mRNA was readily measured in rat brain and lung (ϳ0.4 pg/g total RNA). The oatp3 mRNA was also detected at levels just above background in spleen, liver, and hepatocyte but was undetectable by RPA in heart and kidney. Thus 5Ј-and 3Ј-probes were unable to detect oatp3 mRNA in kidney. As shown previously (1), the oatp3 mRNA was also expressed in retina (ϳ0.04 pg/g total RNA). However, in contrast to the previous report, retinal oatp3 mRNA was present at levels significantly below that of whole brain. In addition, since human ASBT EST clones (GenBank accession nos. AA504910 and AA504859) have been reported from a human fetal retinal cDNA library, ASBT expression was also investigated in rat retina. Unlike oatp3, ASBT was not detectable in retinal RNA by RPA (data not shown), suggesting that the human ASBT sequences were obtained from contaminating genomic clones.
The affinity-purified antibody, designated ␣GST-oatp3, was used for immunolocalization of the oatp3 protein in transfected cells and in intestinal tissue. Figure 7 shows that ␣GST-oatp3 strongly reacted with the oatp3-transfected cells (Fig. 7F) . The antibody also cross-reacted with oatp1 ( Fig. 7B) but not oatp2 (Fig.  7D) . The lack of cross-reactivity with oatp2 was not due to low expression in the transfected COS cells. Parallel dishes of oatp1-, oatp2-, and oatp3-transfected COS cells exhibited similar levels of [ 3 H]taurocholate uptake (data not shown). The oatp3 immunolocalization studies then focused on rat small intestine, where oatp1 is not expressed (Fig. 5A) . Cryosections from rat jejunum were incubated with an ammonium sulfateprecipitated fraction from preimmune serum or the affinity-purified ␣GST-oatp3 (Fig. 8) . The preimmune antibody had no reactivity (Fig. 8A) , whereas ␣GST- oatp3 stained the apical membrane of epithelial cells (Fig. 8, B and C) . Goblet cells (arrows in Fig. 8 , B and C) were not labeled.
Isolation of oatp3 cDNA from mouse brain. A search of the EST database yielded two overlapping mouse EST clones, one from skin and one from mammary gland (GenBank accession nos. AA690580 and AA612385), with significant identity to rat oatp3. A contig of the two clones encompassed 499 bp of coding region and 434 bp of 3Ј-untranslated sequence. At the nucleotide level, the coding region of this contig shares 92% identity with the rat oatp3 coding region and Ͻ86% identity with other members of the family. In addition, the contig and the rat oatp3 share ϳ81% identity along the length of their 3Ј-untranslated regions, whereas the 3Ј-untranslated regions of the other oatp family members shares Ͻ50% identity. At the amino acid level, the contig shares 92% identity with the rat oatp3 and Ͻ78% identity with other members of the oatp family. This very high degree of sequence identity indicates that the EST clones represent the mouse ortholog of the rat oatp3. The sequence of the complete mouse oatp3 cDNA (GenBank accession no. AF240694) was obtained by 5Ј-RACE. The cDNA includes 94 bp of 5Ј-untranslated sequence, a 2,010-bp coding region, and 434 bp of 3Ј-untranslated region. The 3Ј-untranslated sequence included a canonical polyadenylation signal (AATAAA) located at position 2519 and was followed by a 22-nt poly(A) tail. The initiator methionine lies in an appropriate consensus for initiation of translation (26) and is preceded by an in-frame stop codon. An upstream ATG codon is closely followed by an in-frame stop codon. The 2,010-bp open reading frame encodes a 670-amino acid polypeptide with a calculated molecular mass of 74,758 Da and a putative topology of 12 transmembrane domains (45) . The predicted mouse oatp3 protein sequence is 90, 80, 82, 78, 43, and 35% identical to the rat oatp3, oatp1 (22) , oatp2 (35), oatk1 (38) , lst-1 (23), and PGT (25), respectively (Table 3) .
Chromosomal localization of the mouse oatp3 gene. To determine the chromosomal location of the mouse oatp3 gene, two mouse oatp3 3Ј-untranslated regionspecific oligonucleotide primers were used to screen a (2 g) from rat liver (L; lanes 2, 5, and 8) and small intestine mucosal cells (I; lanes 3, 6, and 9) was reverse transcribed and used for PCR amplification with oligonucleotide primers specific for rat oatp1, oatp2, or oatp3. A separate reaction was performed in the absence of cDNA (H 2 O; lanes 1, 4, and 7) as a control for contamination. Amplified products were separated on a 1% (wt/vol) agarose gel and visualized with ethidium bromide. A fragment of cyclophilin was also amplified from each cDNA reaction to serve as a load control (data not shown). B: expression of oatp3 and ASBT mRNA along the longitudinal axis of the small intestine. The entire rat small intestine was divided into 9 equal segments and used to prepare mucosal scrapings for RNA isolation. Yeast tRNA (10 g; lanes 1 and 2) and the indicated amount of total RNA were used to quantitate the expression of rat oatp3 (50 g), rat ASBT (5 g), and actin (5 g) by RNase protection assay. The rat oatp3 probe used for these assays encompassed nt 2051-2404. After hybridization of the 32 P-labeled probes, samples were incubated in the absence (lane 1) or presence (lanes 2-11) of a mixture of RNase A and T1, and the protected products were resolved by electrophoresis on a 6% acrylamide-7 M urea denaturing gel. The amount of protected riboprobe was quantitated using a PhosphorImager; the absolute amount of specific transcript was estimated from a standard curve using in vitro transcribed sensestrand standards analyzed in parallel. : lanes 1, 2, 10, and 11 ) and total RNA (50 g: lanes 3-9; 10 g: lanes 12 and 13) from the indicated rat tissues were hybridized with a rat oatp3 32 P-labeled riboprobe corresponding to only 3Ј-untranslated region sequence (nt 2288-2404). The hybridization reaction was incubated in the absence (lanes 1 and 10) or presence (lanes 2-9 and 11-13) of a mixture of RNase A and T1. The protected products were resolved by electrophoresis on a 6% acrylamide-7 M urea denaturing gel. The amount of protected riboprobe was quantitated using a PhosphorImager; the absolute amount of specific transcript was estimated from a standard curve using in vitro transcribed sense-strand standards analyzed in parallel. Bottom: parallel samples of RNA (5 g: lanes 3-9; 2 g: lanes 12 and 13) were hybridized with a 32 P-labeled actin riboprobe and analyzed as described for top panel.
mouse/hamster radiation hybrid panel by PCR. The retention patterns were submitted to the Jackson Laboratories Mouse Radiation Hybrid Database, where linkage analysis was performed. An optimal logarithm of odds score of 13.0 was obtained with marker D6Mit58. This localizes the mouse oatp3 gene (locus symbol Slc21a7) to a region of mouse chromosome 6 syntenic with human chromosome 12p12. The human OATP-A gene has been localized to this region of chromosome 12 by radiation hybrid analysis (28) and fluorescent in situ hybridization (30) , suggesting that OATP-A is the human ortholog of oatp3. Interestingly, the human LST-1 gene (aliases: OATP-C, OATP2, and SLC21A6) is encoded by a BAC clone (GenBank accession no. AC022335) also mapping to human chromosome 12p (www.hgsc.bcm.tmc.edu/seq_data/projecttable.cgi?submitϭRun&maplocationϭHumanϩ12p). This observation raises the possibility that a cluster of oatp-like genes is encoded in this chromosomal region and that another human ortholog may exist for oatp3. A comparison of the amino acid sequences for OATP-A and rat and mouse oatp3 (Fig. 9 ) reveals identities of 72% shared with both rodent polypeptides. This high degree of identity suggests that oatp3 and OATP-A are orthologous.
DISCUSSION
Bile acid absorption in the jejunum was originally considered to occur only by passive diffusion across the brush-border membrane (11) . However, recent studies in a variety of species indicate that facilitated transport is present in jejunum (3) (4) (5) . This study reports the cloning and analysis of a strong candidate for the facilitative intestinal bile acid transporter oatp3.
The rat oatp3 cDNA shares considerable identity with other members of the rat oatp family, including Fig. 8 . Immunofluorescence localization of oatp3 in rat jejunum. Sections (6 m) of rat jejunum were fixed with 3.7% formaldehyde and permeabilized with 0.1% saponin. The sections were incubated with 2.9 g/ml of ammonium sulfate-precipitated preimmune IgG (A) or 2.9 g/ml affinity-purified ␣GST-oatp3 (B and C). The rabbit antibody was visualized with 25 g/ml rhodamine-conjugated goat anti-rabbit IgG. A and C are combined fluorescence and phasecontrast images; B is a fluorescent image. Arrows indicate locations of goblet cells in the epithelium. oatp1, oatp2, and OAT-K1. The sequence identity extends throughout the coding region and ends abruptly 23-53 nt upstream of the initiator methionine and 41-50 nt downstream of the stop codon. The divergent 3Ј-and 5Ј-untranslated regions indicate that oatp3 is a distinct gene product and not an alternately spliced isoform of a previously identified oatp. The 74-kDa protein encoded by this oatp3 cDNA also shares considerable structural identity with the other known rat oatps. It is predicted to be a polytopic membrane protein with a cytoplasmic amino terminus, 12 putative transmembrane segments, and a cytoplasmic carboxy terminus. The predicted protein contains four potential glycosylation sites, three of which are conserved among the rat oatps.
When expressed in transfected COS cells, rat oatp3 mediates Na ϩ -independent, saturable taurocholate uptake with an apparent K m of 30 M and a V max of 240 pmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 . This K m is similar to that reported for the retinal library-derived oatp3 clone expressed in Xenopus oocytes (18 M) (1), for oatp1 expressed in Xenopus oocytes (50 M) (29), HeLa cells (27 M) (24) , and Chinese hamster ovary (CHO) cells (32 M) (13), and for oatp2 (34 M) (35) and human OATP (60 M) (28) expressed in Xenopus oocytes. In addition, the apparent K m is very similar to the value of 54 M determined for the taurocholate transport by rat jejunal brush-border membrane vesicles (4).
In the rat jejunal brush-border membrane vesicle study, the dihydroxy bile acid taurochenodeoxycholate was transported at twice the rate of the trihydroxy bile acid taurocholate. Also, the K m of taurocholate uptake by the vesicles was approximately twofold greater than the K m of taurochenodeoxycholate uptake (4) . Previous studies of jejunal absorption have also shown a preference for glycine conjugates and dihydroxy bile acids in humans (19, 40) , rabbits (3), and guinea pigs (5). These substrate specificities and relative affinities are similar to those exhibited by rat oatp3 in transfected cells. The greater influence of steroid nucleus hydroxylation than the conjugation on relative affinities as measured in the MDCK-oatp3 stable cells is similar to observations of oatp1-mediated uptake in stably transfected CHO cells (13) . The rat ASBT did not exhibit the trends in substrate specificity observed for rat oatp3. ASBT transported taurochenodeoxycholate and taurocholate at the same rate, in contrast to the observations of the rat jejunal brush-border membrane vesicles. These results support the hypothesis that rat jejunal bile acid uptake is mediated by a distinct transporter and is not due to low levels of ASBT expression in the proximal small intestine (4, 5) .
The demonstration of Na ϩ -independent but bicarbonate trans-stimulated taurocholate uptake by rat jejunal brush-border membrane vesicles (4) also supports the presence of a bile acid transporter distinct from the ASBT. Like other oatps (22, 25, 28, 35, 38) , rat oatp3-mediated transport is Na ϩ independent. The oatp3 may also be trans-stimulated by bicarbonate. Oatp3 shares extensive similarity with oatp1, which has been shown to function as a taurocholate/bicarbonate exchanger (39) . Taurocholate uptake by the rat jejunal brush-border membrane vesicles (4) and by oatp3 is sensitive to the general anion transport inhibitor DIDS. Preincubation with 250 M DIDS inhibited rat brush-border membrane taurocholate uptake by 81% (4). In rat oatp3-transfected COS and MDCK cells, the same concentration of DIDS inhibited taurocholate uptake to a comparable degree (59%).
The similar bile acid transport kinetics, substrate specificity, Na ϩ independence, and DIDS sensitivity shared by jejunal brush-border membrane vesicles and oatp3 suggest that oatp3 is the carrier responsible for the jejunal absorption of bile acids described by Amelsberg and colleagues (4, 5) . Furthermore, the apical localization of oatp3 in MDCK cells, a model system for epithelial cell polarity, suggested that the transporter is expressed on the appropriate membrane to act as the brush-border membrane Na ϩ -independent bile acid transporter.
The expression of oatp3 mRNA down the length of the small intestine is consistent with the hypothesis that oatp3 is the facilitative carrier responsible for intestinal passive absorption of bile acids. The other known bile acid-transporting rat oatps, oatp1 and oatp2, are not candidates, because they are not detected in the small intestine by Northern blot analysis (22) , RT-PCR (38), or RPA. Staining of the apical membranes of jejunal epithelial cells by the oatp3 antibody confirmed that the protein is expressed in the small intestine on the jejunal apical brush-border membrane. The weak but reproducible staining by the antioatp3 antibody as well as the low level of oatp3 mRNA expression in the small intestine compared with ASBT may explain the previous difficulty in distinguishing Na ϩ -independent facilitated transport from membrane Human OATP-A  67  68  72  72  72  66  Rat oatp1  67  81  76  80  80  74  Mouse oatp1  68  81  77  80  81  74  Rat oatp2  72  76  77  82  82  76  Rat oatp3  72  80  80  82  90  76  Mouse oatp3  72  80  81  82  90  77  Rat oatp5  66  74  74  76  76  77 Amino acid sequences were compared using the Blastn matrix OBLOSUM 62 program without a filter (17) .
diffusion of bile acids (3, 5, 11) . Further studies to quantitate the oatp3 protein and activity in the small intestine are required to estimate the potential capacity of this system in humans and experimental animal models. The expression of oatp3 mRNA in rat brain, lung, and retina in addition to small intestine indicates that oatp3 must transport other solutes in addition to bile acids. This is not surprising given the broad substrate specificity demonstrated for the related oatps (13, 34) . Oatp3 expressed in Xenopus oocytes has been shown to transport the triiodothyronine and thyroxine forms of thyroid hormone (1) . Although other substrates for oatp3 remain to be determined, its intestinal expression and potentially broad substrate specificity suggest that oatp3 may play an important role in the absorption of other nutrients and drugs. In a previously reported Northern blot analysis (1), the rat oatp3 cDNA hybridized with abundant transcripts in rat kidney and retina. In contrast, this study employing an RPA showed that oatp3 mRNA was present in retina at levels much lower than in brain and was not detected in kidney. It is likely that the discrepancy is due to cross-hybridization of the oatp3 probe with related oatp transcripts expressed in these tissues; the Sma I fragment used previously as a probe for the Northern blot analysis encompassed 260 nt of Fig. 9 . Comparison of the rodent oatp3 and human OATP-A protein sequences. The predicted amino acid sequences of the mouse and rat oatp3 and the human OATP-A were aligned using the ClustalW program provided by the San Diego Supercomputer Center. Shaded residues are conserved in all 3 sequences. Predicted transmembrane domains were identified using Hidden Markov model analysis (45) and are underlined. *, Potential N-linked glycosylation sites.
coding sequence that is highly conserved between the oatp family members. In contrast, the RNase protection probe used in this study was derived solely from divergent 3Ј-untranslated region sequence. Unfortunately, it has not been possible to directly compare the sequences of the probes used in these studies, since the untranslated region sequence of the retinal library oatp3 cDNA remains unpublished (1) . The oatp3 expression pattern differences could also be explained by differences in the rat strains used in the two studies.
The high degree of sequence identity, particularly in the 3Ј-untranslated region, argues that the novel mouse cDNA in this study is orthologous to rat oatp3 and human OATP-A. The assignment of mouse and rat oatp3 as the rodent orthologs of human OATP-A was further supported by localization of the mouse oatp3 to a region of chromosome 6 syntenic with human chromosome 12p12 (28, 30) . Kullak-Ublick et al. (30) showed by Northern blot analysis that OATP-A, like oatp3, is expressed at relatively high levels in brain and lung. Lower levels detected in the kidney and liver may represent cross-hybridization of the coding region probe with other members of the family or species differences. No OATP-A RNA was detected in small intestine. However, the low levels of oatp3 measured in rat intestine by RPA may be below the level of detection by Northern blot analysis. The uptake values of only six substrates are available for rat oatp3 and human OATP-A. Both proteins mediate transport of cholate, taurocholate, and tauroursodeoxycholate, although the K m of cholate varies greatly for the two transporters (8.8 M for oatp3 and 93 M for OATP-A). The cyanobacterial toxin microcystin is transported by OATP-A (14) but not by rat oatp3, and neither protein transports digoxin or methotrexate (35) . The different transport properties may represent real species differences or differences between experimental systems.
It is widely accepted that active Na ϩ -dependent transport is the predominant mechanism for intestinal bile acid absorption and maintenance of the enterohepatic circulation under normal physiological conditions (20) . However, the question of what fraction of the bile acid pool is absorbed by mechanisms other than the ASBT has not been fully resolved in humans or in experimental animal models. The identification of a second apical intestinal carrier for bile acids provides a molecular mechanism for the non-ASBT-mediated absorption and has important physiological and therapeutic implications. In pathophysiological states in which ASBT function is compromised, such as ileal resection (9) , primary bile acid malabsorption (36) , and ileal inflammation (44) , induction of oatp3 may slow bile acid loss. In contrast, induction of oatp3-mediated intestinal bile acid absorption would compromise the efficiency of specific ASBT inhibitors being developed to treat hypercholesterolemia (27) . Identification of the oatp3 in small intestine will facilitate studies, including knockout mouse models, to define the quantitative significance of this pathway for the absorption of bile acids, other nutrients, and drugs under physiological and pathophysiological conditions.
